Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Houben

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2007
IGF-1 CA repeat variant and breast cancer risk in postmenopausal womenA M González-Zuloeta Ladd, F Liu, M P W A Houben, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2025
Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective studyFrancesca Rita Ogliari, Mandy Jongbloed, Rianne D W Vaes, et al.
The Lancet. Oncology|August 11, 2022
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry studySabine R de Wild, Linda de Munck, Janine M Simons, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 24, 2014
Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancerCéline M H Op den Kamp, Dirk K M De Ruysscher, Marieke van den Heuvel, et al.
The Lancet. Oncology|June 29, 2026
Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry studyAnnefleur J W Mauritz, Linda de Munck, Janine M Simons, et al.
Trials|May 22, 2024
High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial)C M L Zegers, A Swinnen, C Roumen, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2007
IGF-1 CA repeat variant and breast cancer risk in postmenopausal womenA M González-Zuloeta Ladd, F Liu, M P W A Houben, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2025
Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective studyFrancesca Rita Ogliari, Mandy Jongbloed, Rianne D W Vaes, et al.
The Lancet. Oncology|August 11, 2022
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry studySabine R de Wild, Linda de Munck, Janine M Simons, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 24, 2014
Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancerCéline M H Op den Kamp, Dirk K M De Ruysscher, Marieke van den Heuvel, et al.
The Lancet. Oncology|June 29, 2026
Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry studyAnnefleur J W Mauritz, Linda de Munck, Janine M Simons, et al.
Trials|May 22, 2024
High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial)C M L Zegers, A Swinnen, C Roumen, et al.
Pageof 12